Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing
Go back to Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing| (NASDAQ: RANI) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $ | |||
| Open | $0.80 | 52 Week Low | $ | |||
| Day High | $0.83 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $ | |||
| Volume | 318,219 | |||||
